Unresectable Stage III NSCLC
5 clinical trials · Condition
◉ Watch Unresectable Stage III NSCLC
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC (NCT04982549) | Shandong Cancer Hospital and Institute | 2021-01-21 |
| Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab. (NCT04381494) | AstraZeneca | 2020-04-27 |
| Endostar Combined With Concurrent Radiochemotherapy for Treatment of Unresectable Stage III NSCLC (NCT04161352) | Zhejiang Cancer Hospital | 2019-11-25 |
Track Unresectable Stage III NSCLC automatically
Every clearance here is in the API, with alerts when new ones post.